Cost-Effectiveness of Posaconazole Tablets for Invasive Fungal Infections Prevention in Acute Myelogenous Leukemia or Myelodysplastic Syndrome Patients in Spain

INTRODUCTION: Posaconazole is superior to fluconazole (FLU) and itraconazole (ITRA) in the prevention of invasive fungal diseases (IFDs) in neutropenic patients with acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS). A new tablet formulation of posaconazole with improved pharmacoki...

Descripción completa

Detalles Bibliográficos
Autores principales: Cámara, Rafael, Gozalbo, Irmina, Jurado, Manuel, Sanz, Jaime, Aragón, Belén, Grau, Santiago
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599452/
https://www.ncbi.nlm.nih.gov/pubmed/28808915
http://dx.doi.org/10.1007/s12325-017-0600-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599452/
https://www.ncbi.nlm.nih.gov/pubmed/28808915
http://dx.doi.org/10.1007/s12325-017-0600-1

Ejemplares similares